MedPath

Meiziya MLADY Capsules

Registration Number: MAL13115162TC

Approved
Approval ID

cdad7bacfde081f9

Registration Number

MAL13115162TC

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

28 CapsulesAvailable
Package Size: 28 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (9)

Paeonia lactifloraActive
Glehnia littoralisActive
Monograph: glehnia littoralis
Ophiopogon japonicusActive
Monograph: ophiopogon japonicus
Polygonum multiflorumActive
Monograph: polygonum multiflorum
Rehmannia GlutinosaActive
Lycium barbarumActive
Monograph: lycium barbarum
Schisandra chinensisActive
Angelica sinensisActive
Salvia miltiorrhizaActive

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Meiziya MLADY Capsules - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform